Galloylquinic Acids Compounds from Copaifera lucens Dwyer Augment the Antitumor Efficacy of Doxorubicin in Ehrlich Ascites Carcinoma-bearing Mouse Model and Modulate ANXA1 Level in Breast Cancer Cells In Vitro

Vol 9, 2023 - 158375
Poster
Favorite this paper
How to cite this paper?
Abstract

Galloylquinic acid compounds (BF) augmented the antitumor efficacy of Doxorubicin in vivo
BF modulated ANXA1 level in breast cancer cells in vitro
BF increased the mean survival time of mice, inhibited ascites tumor cell count and decreased tumor volume
BF modulated body weight changes and multi-organ histopathological alterations
Treatment with BF reverted oxidative stress, restore liver and kidney functions, and blood cell count to normal values

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin D02 VN51, Ireland
  • 2 Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 11152 Egypt
  • 3 Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP), Universidade de São Paulo (USP)
  • 4 Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, Alexandria University, 21500 Alexandria, Egypt
Track
  • 2. Biological and Pharmacological Activity of Natural Products
Keywords
Galloylquinic acid compounds; Ehrlich ascites carcinoma; Breast cancer; Annexin A1; Doxorubicin